CAROL: LET’S TURN TO THE CORONAVIRUS PANDEMIC AND YOUR TOP HEADLINES THIS EVENING. THE PRESIDENT THIS AFTERNOON CALLED ON GOVERNORS ACROSS THE COUNTRY TO ALLOW CHURCHES AND PLACES OF WORSHIP TO OPEN. HE SAID IF THEY DON'T, HE WILL OVERRIDE THEM. THE CDC ANNOUNCED NEW GUIDELIN FOR PLACES OF WARSHIP THEY’RE , ENCOURAGING THE USE…
GABBY: WE WANT TO GET YOU BACK TO THE NUMBERS. FROM SOUTH CAROLINA HEALTH OFFICIALS AND THEY ARE REPORTING 11 MORE DEATHS ASSOCIATED WITH COVID-19 IN THE STATE BRINGING THE TOTAL TO 135 PEOPLE NOW. OFFICIALS JUST RELEASED THESE NUMBERS A FEW MOMENTS AGO. WE ARE TOLD THERE ARE 460 EIGHT POSITIVE CASES ACROSS SOUTH…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f